Epizyme
Latest round
- Series C
Last raised
- Apr 2012
Total raised
- $65M
Investors
- 7
About Epizyme
Epizyme, Inc.Epizyme, Inc. was founded in 2007 in Cambridge, US, and is dedicated to creating targeted therapies through epigenetic research. The company underwent a pivotal change when it was acquired by Ipsen Group in June 2022 for USD 247 mn.Epizyme, Inc. offers a portfolio of transformative medicines primarily targeting oncology and rare diseases. Their flagship products include Tazemetostat, used in the treatment of epithelioid sarcoma and relapsed or refractory follicular lymphoma.For the year 2021, Epizyme, Inc.Future growth for Epizyme, Inc. includes plans for the continued development of new treatments targeting various cancers and rare diseases, with a focus on launching new products in the coming years. This strategic direction follows a series of successful fundraising efforts, including the recent acquisition that is planned to bolster their portfolio and operational resources.
Who invested in Epizyme
7 investors across 4 rounds
See all investors in Epizyme
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Epizyme
Who invested in Epizyme?
Epizyme has 7 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Epizyme raised?
Epizyme has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Epizyme last raise money?
Epizyme's most recent round on record is a Series C, in Apr 2012.
What does Epizyme do?
Epizyme is a biotechnology company.
Where is Epizyme headquartered?
Epizyme is headquartered in Cambridge, US.
Which VCs invest in companies like Epizyme?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Epizyme's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Epizyme? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.